Cukierman & Co. Life Sciences
Sephora Sackmann serves as Vice President at Cukierman & Co. Life Sciences since January 2022, following a progression from Senior Associate to Associate at Cukierman & Co. Investment House between June 2015 and December 2023. In these roles, Sephora Sackmann has provided assistance to various life sciences companies—including those in biotechnology, pharmaceuticals, diagnostics, medical devices, artificial intelligence, and digital health—in identifying, negotiating, and closing equity deals, venture debts, licensing agreements, strategic partnerships, and M&A transactions. Additionally, support has been extended to venture capital and private equity funds, private investors, family offices, and corporate development teams in evaluating and managing transactions across life sciences sectors. Prior experience includes roles as a Junior Analyst at Cukierman & Co. Investment House and a Business Analyst at Hewlett-Packard. Educational credentials include a Master of Science in Management with a focus on finance from Grenoble Ecole de Management and preparatory classes at Classe préparatoire Commercia.
This person is not in any teams
This person is not in any offices
Cukierman & Co. Life Sciences
Established in 2006, Cukierman & Co. Life Sciences (CLS) which constitutes CIH’s largest Investment Banking Practice, provides financial advisory services to private and public companies, at different stages of development, across the whole healthcare spectrum, in Israel, Europe, Asia and America with strategic partners. Cukierman & Co. Life Sciences mission is to assist: Biotechnology, pharmaceuticals, diagnostics, medical devices, artificial intelligence and digital health companies in identifying, negotiating and closing equity and venture debts, licensing agreements, strategic partnerships and M&A transactions; We support venture capital & private equity funds, private investors & family offices, corporate funds & corporate development teams, in selecting, evaluating, acquiring and divesting assets, businesses and companies in all life sciences sectors. CLS talented team of scientific, medical, finance and business experts, jointly with our extensive international network, provides corporate guidance and global industry knowledge for fundraising and financial transactions.